BURLINGAME, Calif.--(BUSINESS WIRE)--Bill Garner, Chief Executive Officer of Urigen Pharmaceuticals (OTCBB: URGP) (www.urigen.com), updated the investment community in an interview with www.wallst.net. Topics covered in the interview include an overview of the company, its therapeutic development programs for urological disorders, growth strategy, recent press releases, market opportunities, and upcoming milestones for investors to watch for.
